Literature DB >> 26596632

Asthma and chronic obstructive pulmonary disease overlap: asthmatic chronic obstructive pulmonary disease or chronic obstructive asthma?

Annelies Slats1, Christian Taube2.   

Abstract

Asthma and chronic obstructive pulmonary disease (COPD) are different disease entities. They are both clinical diagnoses, with diagnostic tools to discriminate between one another. However, especially in older patients (>55 years) it seems more difficult to differentiate between asthma and COPD. This has led to the definition of a new phenotype called asthma COPD overlap syndrome (ACOS). However, our understanding of ACOS is at a very preliminary stage, as most research has involved subjects with existing diagnoses of asthma or COPD from studies with different definitions for ACOS. This has led to different and sometimes opposing results between studies on several features of ACOS, also depending on the comparison with COPD alone, asthma alone or both, which are summarized in this review.We suggest not using the term ACOS for a patient with features of both asthma and COPD, but to describe a patient with chronic obstructive airway disease as completely as possible, with regard to characteristics that determine treatment response (e.g. eosinophilic inflammation) and prognosis (such as smoking status, exacerbation rate, fixed airflow limitation, hyperresponsiveness, comorbidities). This will provide a far more clinically relevant diagnosis, and would aid in research on treatment in more homogenous groups of patients with chronic airways obstruction. More research is certainly needed to develop more evidence-based definitions for this patient group and to evaluate biomarkers, which will help to further classify these patients, treat them more adequately and unravel the underlying pathophysiological mechanism.
© The Author(s), 2015.

Entities:  

Keywords:  asthma chronic obstructive pulmonary disease overlap syndrome; phenotype

Mesh:

Year:  2015        PMID: 26596632      PMCID: PMC5933660          DOI: 10.1177/1753465815617082

Source DB:  PubMed          Journal:  Ther Adv Respir Dis        ISSN: 1753-4658            Impact factor:   4.031


  98 in total

1.  Asthma attacks with eosinophilia predict mortality from chronic obstructive pulmonary disease in a general population sample.

Authors:  J J Hospers; J P Schouten; S T Weiss; B Rijcken; D S Postma
Journal:  Am J Respir Crit Care Med       Date:  1999-12       Impact factor: 21.405

2.  Understanding the pathophysiology of the asthma-chronic obstructive pulmonary disease overlap syndrome.

Authors:  Arthur F Gelb; Jay A Nadel
Journal:  J Allergy Clin Immunol       Date:  2015-09       Impact factor: 10.793

3.  Bronchoscopic evaluation of severe asthma. Persistent inflammation associated with high dose glucocorticoids.

Authors:  S E Wenzel; S J Szefler; D Y Leung; S I Sloan; M D Rex; R J Martin
Journal:  Am J Respir Crit Care Med       Date:  1997-09       Impact factor: 21.405

4.  Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial.

Authors:  P S Burge; P M Calverley; P W Jones; S Spencer; J A Anderson; T K Maslen
Journal:  BMJ       Date:  2000-05-13

5.  Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. International COPD Study Group.

Authors:  P L Paggiaro; R Dahle; I Bakran; L Frith; K Hollingworth; J Efthimiou
Journal:  Lancet       Date:  1998-03-14       Impact factor: 79.321

6.  Stable COPD: predicting benefit from high-dose inhaled corticosteroid treatment.

Authors:  R Leigh; M M M Pizzichini; M M Morris; F Maltais; F E Hargreave; E Pizzichini
Journal:  Eur Respir J       Date:  2006-01-30       Impact factor: 16.671

7.  Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. The Lung Health Study Research Group.

Authors:  D P Tashkin; M D Altose; J E Connett; R E Kanner; W W Lee; R A Wise
Journal:  Am J Respir Crit Care Med       Date:  1996-06       Impact factor: 21.405

8.  The clinical and genetic features of COPD-asthma overlap syndrome.

Authors:  Megan Hardin; Michael Cho; Merry-Lynn McDonald; Terri Beaty; Joe Ramsdell; Surya Bhatt; Edwin J R van Beek; Barry J Make; James D Crapo; Edwin K Silverman; Craig P Hersh
Journal:  Eur Respir J       Date:  2014-05-29       Impact factor: 16.671

9.  Systemic inflammation and COPD: the Framingham Heart Study.

Authors:  Robert E Walter; Jemma B Wilk; Martin G Larson; Ramachandran S Vasan; John F Keaney; Izabella Lipinska; George T O'Connor; Emelia J Benjamin
Journal:  Chest       Date:  2007-10-01       Impact factor: 9.410

10.  Systemic Inflammation in Older Adults With Asthma-COPD Overlap Syndrome.

Authors:  Juan-Juan Fu; Vanessa M McDonald; Peter G Gibson; Jodie L Simpson
Journal:  Allergy Asthma Immunol Res       Date:  2014-06-10       Impact factor: 5.764

View more
  9 in total

1.  Siglec-8 and Siglec-9 binding specificities and endogenous airway ligand distributions and properties.

Authors:  Huifeng Yu; Anabel Gonzalez-Gil; Yadong Wei; Steve M Fernandes; Ryan N Porell; Katarina Vajn; James C Paulson; Corwin M Nycholat; Ronald L Schnaar
Journal:  Glycobiology       Date:  2017-07-01       Impact factor: 4.313

2.  Obstructive Lung Disease and Obstructive Sleep Apnea (OLDOSA) cohort study: 10-year assessment.

Authors:  Octavian C Ioachimescu; Nicholas J Janocko; Mary-Margaret Ciavatta; Marjorie Howard; Megan V Warnock
Journal:  J Clin Sleep Med       Date:  2020-01-13       Impact factor: 4.062

3.  Changes in the Burden of Comorbidities in Patients with COPD and Asthma-COPD Overlap According to the GOLD 2017 Recommendations.

Authors:  András Bikov; Alpár Horváth; Gábor Tomisa; Liza Bártfai; Zoltán Bártfai
Journal:  Lung       Date:  2018-07-14       Impact factor: 2.584

4.  Epidemiology and risk factors of asthma-chronic obstructive pulmonary disease overlap in low- and middle-income countries.

Authors:  Brooks W Morgan; Matthew R Grigsby; Trishul Siddharthan; Muhammad Chowdhury; Adolfo Rubinstein; Laura Gutierrez; Vilma Irazola; J Jaime Miranda; Antonio Bernabe-Ortiz; Dewan Alam; Robert A Wise; William Checkley
Journal:  J Allergy Clin Immunol       Date:  2018-10-04       Impact factor: 10.793

5.  Low-dose oral cadmium increases airway reactivity and lung neuronal gene expression in mice.

Authors:  Joshua D Chandler; Cherry Wongtrakool; Sophia A Banton; Shuzhao Li; Michael L Orr; Dana Boyd Barr; David C Neujahr; Roy L Sutliff; Young-Mi Go; Dean P Jones
Journal:  Physiol Rep       Date:  2016-07

6.  Spirometry is not enough to diagnose COPD in epidemiological studies: a follow-up study.

Authors:  Elena Andreeva; Marina Pokhaznikova; Anatoly Lebedev; Irina Moiseeva; Olga Kuznetsova; Jean-Marie Degryse
Journal:  NPJ Prim Care Respir Med       Date:  2017-11-14       Impact factor: 2.871

Review 7.  Pharmacological strategies to reduce exacerbation risk in COPD: a narrative review.

Authors:  Marc Miravitlles; Anthony D'Urzo; Dave Singh; Vladimir Koblizek
Journal:  Respir Res       Date:  2016-09-10

8.  Plasma YKL-40 and NGAL are useful in distinguishing ACO from asthma and COPD.

Authors:  Jing Wang; Huajie Lv; Zhuang Luo; Shan Mou; Jing Liu; Chang Liu; Shiying Deng; Youfan Jiang; Jiachen Lin; Chengzhou Wu; Xianhong Liu; Jinzhi He; Depeng Jiang
Journal:  Respir Res       Date:  2018-03-27

9.  Effect of the asthma-chronic obstructive pulmonary disease syndrome on the stroke, Parkinson's disease, and dementia: a national cohort study.

Authors:  Jun-Jun Yeh; Yu-Feng Wei; Cheng-Li Lin; Wu-Huei Hsu
Journal:  Oncotarget       Date:  2017-12-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.